MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

StemCells Company Profile (NASDAQ:STEM)

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $17.06 (4,267.48% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016S&P Equity ResearchLower Price Target$0.39 -> $0.33View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Maxim GroupDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Rodman & RenshawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Chardan CapitalReiterated RatingBuy$12.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015HC WainwrightLower Price TargetBuy$25.20 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Cantor FitzgeraldReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Ascendiant Capital MarketsReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Brinson PatrickInitiated CoverageOutperform$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for StemCells (NASDAQ:STEM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/6/2016        
3/23/2016Q4($0.09)($0.07)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015($0.10)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.09)($0.09)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q1($0.14)($0.11)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q4($0.12)($0.14)$220.00 million$883.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014($0.13)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q2($0.14)($0.22)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2014Q1($0.12)($0.14)$0.24 million$0.34 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2014Q4($0.13)($0.13)$0.22 million$0.31 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q113($0.13)($0.17)$0.29 million$0.28 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/21/2013Q412($0.14)($0.07)$0.31 million$0.21 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for StemCells (NASDAQ:STEM)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for StemCells (NASDAQ:STEM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for StemCells (NASDAQ:STEM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/29/2015Kenneth Blair StrattonGeneral CounselSell104,549$0.45$47,047.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for StemCells (NASDAQ:STEM)
DateHeadline
06/25/16 05:59 PMFriday's Highlights at Noon: StemCells Inc (STEM), MannKind Corporation (MNKD), Threshold Pharmaceuticals (THLD ... - Analyst Ratings
06/23/16 07:18 PMHC Stocks in Hub: Johnson & Johnson (NYSE:JNJ), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/23/16 09:11 AMSpinal Cord Injury Pipeline Market 2016 Global Forecast Analysis Research
06/22/16 09:59 AMTuesday's Mid-Day Stock Update: IsoRay Inc (ISR), StemCells Inc (STEM), Lpath Inc (LPTN), Threshold ... - Analyst Ratings
06/21/16 06:07 PMWhat Analyst's have to say about StemCells Inc (NASDAQ:STEM) - iStreetWire
06/21/16 06:07 PMStrong Buy Calls Count For StemCells, Inc. (NASDAQ:STEM) At 0 - Investor Newswire
06/20/16 06:11 PMU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.73%
06/19/16 10:15 AMForm 4 STEMCELLS INC For: Jun 17 Filed by: Stratton Kenneth Blair
06/18/16 10:31 AMFriday's Mid-Day Stock Update: StemCells Inc (STEM), Sunshine Heart Inc (SSH), Advanced Micro Devices (AMD ... - Analyst Ratings
06/17/16 06:19 PMRecently Issued Stock Ratings For StemCells, Inc. (STEM) - Fiscal Standard
06/15/16 06:31 PMHC Trending Hot Stocks: Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/13/16 09:37 AMHC Stocks Overview: Chimerix Inc (NASDAQ:CMRX), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/10/16 06:59 PMHC Stocks Impression: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/09/16 09:40 AMUpdated Trading Report: ImmunoGen, Inc. (NASDAQ:IMGN) , StemCells, Inc. (NASDAQ:STEM) - Street Updates
06/08/16 09:44 AMHC Stocks Focal Point: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/08/16 09:44 AMStocks within Traders Screening: StemCells, Inc. (NASDAQ:STEM) , Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) - Street Updates
06/07/16 06:54 PMEarnings Overview of the Stocks: Liberty Broadband Corporation (NASDAQ:LBRDK), StemCells Inc. (NASDAQ:STEM) - Beacon Chronicle
06/07/16 09:24 AMMaxim Group Downgrades StemCells Inc to Hold - Trade Calls
06/03/16 07:16 PMEarnings Stocks Analysis: StemCells Inc. (NASDAQ:STEM), Towerstream Corporation (NASDAQ:TWER) - Beacon Chronicle
06/03/16 07:16 PMMid-day Market Update: StemCells Inc (NASDAQ:STEM) - The Point Review
06/03/16 09:36 AMHC Stocks Analysis: StemCells Inc (NASDAQ:STEM), Pfizer Inc. (NYSE:PFE) - share market updates (press release)
06/02/16 07:05 PMStemCells, Inc. (NASDAQ:STEM) Set To Release Quarterly Earnings - Investor Newswire - StemCells, Inc. (NASDAQ:STEM) Set To Release Quarterly EarningsInvestor NewswireAccording to a group of market experts surveyed by Zacks Research, StemCells, Inc. (NASDAQ:STEM) is projected to report earnings of $-0.44 for its recent quarter. The company plans to release its quarterly report on or around 2016-06-07. It should be ...and more »
06/02/16 09:48 AMEarnings Report of the Stock: BlackBerry Limited (NASDAQ:BBRY), StemCells Inc. (NASDAQ:STEM) - Beacon Chronicle - Beacon ChronicleEarnings Report of the Stock: BlackBerry Limited (NASDAQ:BBRY), StemCells Inc. (NASDAQ:STEM)Beacon ChronicleLast Trade: The Company closed its last session at $7.25 with the loss of -0.28%. The market capitalization of the company is $3.8 Billion, with the average Volume of 4.82 Million. The stock currently has its 52-Week High range of $9.94 and 52-week low ...and more »
06/02/16 09:48 AMAnalyst Rating Trends to Observe: Boston Scientific Corporation (NYSE:BSX) , StemCells, Inc. (NASDAQ:STEM) - Street Updates - Analyst Rating Trends to Observe: Boston Scientific Corporation (NYSE:BSX) , StemCells, Inc. (NASDAQ:STEM)Street UpdatesOn 6/1/2016, shares of Boston Scientific Corporation (NYSE:BSX) remained unchanged +0.00% in trading session and finally closed at $22.71. The company most recent volume stood at 7.23 million shares as compared to average volume of 9.5 million ...and more »
06/01/16 07:16 PMMomentum Stocks in Focus: StemCells Inc (NASDAQ:STEM), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Array ... - The Point Review - The Point ReviewMomentum Stocks in Focus: StemCells Inc (NASDAQ:STEM), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Array ...The Point ReviewShares of StemCells Inc (NASDAQ:STEM) fell -0.49% to $0.567 at 11:22 AM EDT. The stock attained the volume of 1.69 Million shares recently versus average trading volume of 653,484 shares. If we take a look on its volatility, 14.29 percent was seen in a ...and more »
06/01/16 09:34 AMAnalyst Rating Fluctuations to Observe: StemCells, Inc. (NASDAQ:STEM) , Mylan N.V. (NASDAQ:MYL) - Street Updates - Analyst Rating Fluctuations to Observe: StemCells, Inc. (NASDAQ:STEM) , Mylan N.V. (NASDAQ:MYL)Street UpdatesOn 5/31/2016, StemCells, Inc. (NASDAQ:STEM) ended trading session lower at $0.57 with -81.19%. The company traded a volume of 8.93 million shares as comparison to average volume of 451.07 thousand shares. During the 52 –week period, the stock's ...and more »
05/31/16 06:58 PMStemCells, Inc. (NASDAQ:STEM) Stock Update & Estimates - Stock Tick Tock - StemCells, Inc. (NASDAQ:STEM) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting StemCells, Inc. (NASDAQ:STEM) to post earnings of $-0.82 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued around ...and more »
05/31/16 06:58 PMHC Stocks Newsbeat: StemCells Inc (NASDAQ:STEM), BIO-TECHNE Corp (NASDAQ:TECH) - share market updates (press release) - HC Stocks Newsbeat: StemCells Inc (NASDAQ:STEM), BIO-TECHNE Corp (NASDAQ:TECH)share market updates (press release)Shares of StemCells Inc (NASDAQ:STEM) ended Friday session in green amid volatile trading. The shares closed up +0.06 points or 2.02% at $3.03 with 92,272.00 shares getting traded. Post opening the session at $3.00, the shares hit an intraday low of ...and more »
05/31/16 06:58 PMStemCells to wind down operations after ending mid-stage study - Reuters - Reuters UKStemCells to wind down operations after ending mid-stage studyReutersStemCells Inc said it would wind down operations after the company terminated a mid-stage trial testing its therapy in spinal cord injury, sending its shares plummeting 85 percent. The magnitude of the treatment's effect did not justify continuing the ...StemCells terminates mid-stage study; to wind down opsOrthoSpineNewsall 3 news articles »
05/31/16 06:58 PMAnalyst Update: StemCells Inc, Intellia Therapeutics Inc, and NVIDIA Corporation - Schaeffers Research (blog) - Analyst Update: StemCells Inc, Intellia Therapeutics Inc, and NVIDIA CorporationSchaeffers Research (blog)Analysts are weighing in on stem cell research stock StemCells Inc (NASDAQ:STEM), genome editing specialist Intellia Therapeutics Inc (NASDAQ:NTLA), and visual computing firm NVIDIA Corporation (NASDAQ:NVDA). Here's a quick roundup of today's ...and more »
05/31/16 06:58 PMAnalysts Downgrade Two Volatile Healthcare Stocks: Celator Pharmaceuticals Inc (CPXX), StemCells Inc (STEM) - Smarter Analyst - Smarter AnalystAnalysts Downgrade Two Volatile Healthcare Stocks: Celator Pharmaceuticals Inc (CPXX), StemCells Inc (STEM)Smarter AnalystHealthcare analysts are weighing in today on leukemia drug maker Celator Pharmaceuticals Inc (NASDAQ:CPXX) and biotechnology company StemCells Inc (NASDAQ:STEM), as the stocks turned extremely volatile following acquisition news, and ...and more »
05/31/16 06:58 PMStemCells Reminds Investors the Lessons of Outright Implosion - 24/7 Wall St. - 24/7 Wall St.StemCells Reminds Investors the Lessons of Outright Implosion24/7 Wall St.StemCells, Inc. (NASDAQ: STEM) just reminded investors and speculators alike just how dangerous it can be to invest in biotech and biohealth companies. The company issued a press release signaling the termination of its Phase II Pathway study. It hurts ...StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of DataGlobeNewswire (press release)Unusual Volume Tracker: StemCells Inc. (NASDAQ:STEM)Franklin IndependentWhy StemCells Inc (STEM) Stock Is Cratering TodayInvestorplace.comThe Cerbat Gem -Market Digest -USA TODAYall 15 news articles »
05/31/16 11:05 AMWhy StemCells Inc (STEM) Stock Is Cratering Today - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips StemCells stock plummeted on Tuesday following an announcement that it's ending one of its Phase II studies early due to poor results. The post Why StemCells Inc (STEM) Stock Is Cratering Today appeared first on InvestorPlace.
05/31/16 09:55 AMBay Area biotech's stock crashes after trials fall short of goals - Shares of StemCells Inc. plunged in morning trading Tuesday after the Newark company announced plans to wind down after it ran out of money for its spinal cord injury mid-stage trial. The stock (NASDAQ: STEM) fell by more than 80 percent after StemCells said "it is possible that there will be no liquidating distribution to stockholders." It had just $5.5 million in cash and cash equivalents as of the announcement on Tuesday. StemCells also said that it had terminated its phase II spinal cord injury…
05/29/16 07:09 AMAre Analysts Bullish StemCells Inc (NASDAQ:STEM) After Last Week? - HNN - Are Analysts Bullish StemCells Inc (NASDAQ:STEM) After Last Week?HNNOut of 4 analysts covering StemCells (NASDAQ:STEM), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. StemCells has been the topic of 4 analyst reports since September 2, 2015 according to StockzIntelligence Inc. Below is a ...
05/26/16 04:21 PMEarnings Review and Stock Rundown for StemCells, Inc. (NASDAQ:STEM) - Wall Street Hints and News - Earnings Review and Stock Rundown for StemCells, Inc. (NASDAQ:STEM)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting StemCells, Inc. (NASDAQ:STEM) to post ...and more »
05/26/16 10:13 AMStemCells, Inc. :STEM-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/26/16 07:25 AMWatch-List HC Stocks: Thermo Fisher Scientific Inc. (NYSE:TMO), StemCells Inc (NASDAQ:STEM) - share market updates (press release) - Watch-List HC Stocks: Thermo Fisher Scientific Inc. (NYSE:TMO), StemCells Inc (NASDAQ:STEM)share market updates (press release)Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) ended Wednesday session in green amid volatile trading. The shares closed up +0.56 points or 0.37% at $151.24 with 1.31 million shares getting traded. Post opening the session at $150.84, the shares ...and more »
05/25/16 04:08 PMStemCells, Inc. (NASDAQ:STEM) One-Year Price Target At $18.000 - Investor Newswire - StemCells, Inc. (NASDAQ:STEM) One-Year Price Target At $18.000Investor NewswireFirst Call has set a 52-week price target of $18.000 on StemCells, Inc. (NASDAQ:STEM) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $-0.630 and for underway fiscal at $-2.900. This estimate for next year is ...and more »
05/23/16 09:18 PMCould StemCells Inc Change Direction After This Bearish Wedge Down - Wall Street Hints and News - Could StemCells Inc Change Direction After This Bearish Wedge DownWall Street Hints and NewsThe stock of StemCells Inc (STEM) formed a down wedge with $2.49 target or 14.00% below today's $2.90 share price. The 5 months wedge indicates high risk for the $37.05 million company. If the $2.49 price target is reached, the company will be worth ...
05/23/16 09:18 PMAnalysts Set 1-Year Price Target Of $20.005 On StemCells, Inc. (NASDAQ:STEM) Stock - Investor Newswire - Analysts Set 1-Year Price Target Of $20.005 On StemCells, Inc. (NASDAQ:STEM) StockInvestor NewswireSell-side analysts reveal their outlook on StemCells, Inc. (NASDAQ:STEM) stock. As of 2016-05-22, the stock has ABR of 1. This methodology prompts shareholders to invest in stock if it has a rating of 1. The ABR was known considering the price ...and more »
05/23/16 06:18 PMBRIEF-StemCells Inc files for rights offering for up to $30 mln - * Files for rights offering for up to $30 million - SEC filing Source text for Eikon: Further company coverage:
05/23/16 09:02 AMAfter Last Week What Do Analysts Think Of StemCells, Inc. (STEM) - Share Trading News - After Last Week What Do Analysts Think Of StemCells, Inc. (STEM)Share Trading News04/20/2016 – Rodman & Renshaw began new coverage on StemCells, Inc. giving the company a “buy” rating. They now have a USD 1.5 price target on the stock. 04/19/2016 – StemCells, Inc. had its “buy” rating reiterated by analysts at Maxim Group.
05/21/16 07:33 AMStemCells, Inc. (STEM) Updated Broker Price Targets - Share Trading News - StemCells, Inc. (STEM) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of StemCells, Inc. (STEM). The latest reports which are currently in issue on Friday 20th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
05/20/16 03:45 PMSTEMCELLS INC Files SEC form 8-K, Other Events -
05/19/16 04:13 PMSTEMCELLS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 13, 2016, StemCells, Inc. (the "Company") received an appealable notice of delisting from the Nasdaq Stock Market ("Nasdaq") for failure ...
05/19/16 03:25 PMSTEMCELLS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra -
05/19/16 12:04 PMSTEMCELLS INC Financials -
05/06/16 11:49 AMStemCells, Inc. Announces 1-for-12 Reverse Stock Split - [GlobeNewswire] - NEWARK, Calif., May 06, 2016-- StemCells, Inc., announced today that at its annual stockholders meeting held on May 5, 2016, the Company's stockholders voted to approve a reverse stock split of the Company's ...
05/03/16 05:07 AMSTEMCELLS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year -
About StemCells

StemCells logoStemCells, Inc. is engaged in the research, development, and commercialization of stem cell therapeutics. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies. The Company's lead product development program is its CNS Program, in which it is developing applications for HuCNS-SC cells, its human neural platform technology. It is in clinical development with its HuCNS-SC cells for a range of diseases and disorders of the central nervous system. The CNS consists of the brain, spinal cord and eye, and it is stem cell company in clinical development for indications in all three compartments comprising the CNS, which include with respect to the brain, with respect to the spinal cord and with respect to the eye. The Phase I clinical trial was completed in Pelizeaus-Merzbacher Disease, Neuronal Ceroid Lipofuscinosis and Phase I/II clinical trial in multiple sites for chronic spinal cord injury was completed.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: STEM
  • CUSIP:
Key Metrics:
  • Previous Close: $0.43
  • 50 Day Moving Average: $1.5800
  • 200 Day Moving Average: $3.3912
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $4.57M
  • Current Quarter EPS Consensus Estimate: $-3.1200 EPS
Additional Links:
StemCells (NASDAQ:STEM) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha